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FUNCTIONAL PROPERT IES  OF  A UNIQUE SUBSET OF  
CYTOTOXIC  CD3 + T LYMPHOCYTES THAT EXPRESS Fc 
RECEPTORS FOR IgG (CD16/LEU-1  1 ANT IGEN)  
BY LEWIS L. LANIER,* THOMAS J. KIPPS,* AND JOSEPH H. PHILLIPS* 
From the *Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043; and 
the *Stanford University School of Medicine, Department of Genetics, 
Stanford, California 94305 
Human T lymphocytes were initially identified (1) and distinguished from B 
lymphocytes based on the ability of T cells to form spontaneous rosettes with 
sheep erythrocytes (E). 1 Within the E + subset, Moretta et al. (2) defined a discrete 
subpopulation of cells that bound IgG-coated erythrocytes (EA) via a specific cell 
surface receptor for the Fc region of IgG (FcR). This population was designated 
the T~, subset. These cells have been shown to mediate suppressor cell function 
(2), antibody-dependent cellular cytotoxicity (ADCC) (3), and natural killer (NK) 
cell-mediated cytotoxicity (4, 5). 
Using monoclonal antibodies (mAb) against human T cell differentiation 
antigens, two antigenically and functionally distinct subsets of  E + cells have been 
identified. The majority of E + lymphocytes express the pan-T  cell-associated 
antigens, CD3 and CD5; whereas a minor subset of E + cells lack CD3 (5-7). 
However, most IgG-FcR + cells are contained within this small CD3- fraction (5- 
7). NK cell-mediated cytotoxicity is confined to E + lymphocytes lacking the CD3 
antigen (5). Based on these findings, it was unclear whether functions attributed 
to the T7 subset were mediated by the CD3- (non-T) NK cell fraction or the 
very small proportion of CD3 + T cells that express FcR for IgG. 
Recently, several mAb (anti-Leu-l l ,  VEP 13, B73.1, and 3G8) have been 
produced (8-12) that specifically react with the IgG FcR expressed on NK cells 
and neutrophils. These antibodies do not react with the IgG FcR expressed on 
monocytes or B lymphocytes (8-10, 12). Essentially all NK and ADCC function 
is contained within the small fraction of lymphocytes that express this IgG FcR 
(i.e. CD16/Leu-1 1 antigen) (8-10, 12, 13). 
We (8, 12) and other investigators (9-1 1) reported that these anti-FcR anti- 
bodies did not react with a significant proportion of CD3 + T lymphocytes i olated 
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from peripheral blood, concanavalin A-activated cultures, or mixed lymphocyte 
response cultures. However, several patients with T cell lymphoproliferative 
disorders have been shown (14-17) to coexpress both CD3 antigen and IgG FcR. 
This finding prompted us to investigate whether or not any CD3 ÷ T lymphocytes 
obtained from normal individuals express the IgG FcR detected by the anti-Leu- 
11 mAb. In this report, we show that a functionally unique subset of  cytotoxic 
T lymphocytes in peripheral blood can be identified by coexpression of  the CD3 
and CD16 (Leu-11) antigens. 
Mater ia ls  and Methods  
Preparation of Human Peripheral Blood Leukocytes (PBL). Human peripheral blood from 
random, normal donors was obtained from volunteer donors at our institutes, the 
American Red Cross (San Jose, CA) or the Stanford Blood Center (Palo Alto, CA). 
Mononuclear cells were isolated using Ficoll/Hypaque. In sorting experiments, monocytes 
and B cells were depleted by plastic adherence and nylon wool columns, as described (18). 
Antibodies. All Leu series mAb were prepared at the Becton Dickinson Monoclonal 
Center. Anti-Tac (interleukin 2 receptor [IL-2-R]) antibody was provided by T. Wald- 
mann, National Institutes of Health, Bethesda, MD (19). Anti-Leu-1, anti-Leu-2a, anti- 
Leu-3a, anti-Leu-4, and anti-Leu-5b (E rosette receptor) recognize the CD5, CD8, CD4, 
CD3, and CD2 T cell differentiation a tigens, respectively. Anti-Leu-1 la (IgG1 antibody), 
anti-Leu-1 lb (IgM antibody) and anti-Leu-1 lc (IgG1 antibody that binds a different 
epitope than anti-Leu-1 la and -b) recognize the IgG FcR (CD16) present on essentially 
all NK cells and neutrophils (12). Anti-Leu-15 detects an epitope on the complement 
receptor type 3, CR3 (CD11) (20). Anti-Leu-M3 recognizes an antigen expressed exclu- 
sively on monocytes. Anti-Leu-7 reacts with an antigen present on a subset of NK cells 
and T lymphocytes (8, 21). Anti-Leu-12 detects the CD 19 antigen, expressed on essentially 
all B lymphocytes. 
Isotype switch-variant antibodies of ME I or MA2.1 were used to detect ADCC activity 
(13). The ME1 antibody reacts with HLA-B7, Bw22, Bw42, and B27, whereas the MA2.1 
antibody reacts with HLA-A2. 
FcR were detected using covalently linked dimeric rabbit IgG and fluorescein isothio- 
cyanate (FITC)-conjugated F(ab')~ goat anti-rabbit IgG, provided by J. Titus (NIH) (22, 
23). 
F(ab')2 fragments of anti-Leu-1 la and anti-Leu-4 antibodies (both IgG1 isotype) were 
prepared by pepsin digestion (Worthington Biochemicals, Freehold, NJ) (25 #g pepsin 
per milligram IgG, pH 4.0, 5 h, 37°C) as described by Parham (24). The F(ab')~ fragments 
were purified by size-exclusion high-pressure liquid chromatography. Fragments were 
analyzed for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis u ing 
Coomassie Brilliant Blue R-250 dye for visualization of proteins (25). Antibodies were 
conjugated with FITC (Molecular Probes, Beaverton, OR) or N-hydroxysuccinimidobiotin 
(Pierce Chemical Co., Rockford, IL) as described by Goding (26). All antibodies were 
titrated for specific binding activity by direct or indirect immunofluorescence. The titers 
of the F(ab')2 antibodies were equivalent to the intact molecules. 
Immunofluorescence and Flow Cytometry. Methods of immunofluorescence, flow cytom- 
etry, and data analysis have been presented elsewhere (8, 27, 28). Fluorochrome-conju- 
gated, isotype-matched mAb that do not react with human cells were used to control for 
nonspecific binding in the immunofluorescence assays. For quantitation of fluorescence, 
the variable logarithmic amplifiers were calibrated to span four log decades. On the 
fluorescence histograms, the abscissa was arbitrarily divided into 256 channels, with 64 
channels representing a 10-fold increase in fluorescence. Bydetermining the mean channel 
of a population and converting this number from a logarithmic to a linear value, it was 
possible to compare the relative amounts of fluorescence ofdifferent populations. 
Tumor Cells. All tumor cell lines were obtained from the American Type Culture 
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Collection, Rockville, MD, and were tested monthly to insure against mycoplasma infec- 
tion. 
Cytotoxicity Assays. For NK cytotoxicity assays, 5~Cr-labeled K562 cells were used as 
targets in a 4-h radioisotope-release say, as described (8, 29). ADCC assays were 
performed using the relatively NK-insensitive B lymphoblastoid cell line JY, as described 
(13). JY expresses HLA antigens A2 and B7. 
Proliferation Assays. Lymphocytes were cocultured with mitomycin C-treated tumor 
cell lines as described (30). Proliferation was measured by incorporation of [~H]thymidine 
(30). Lectin-free, purified IL-2 was purchased from Electronucleonics, Inc. (Silver Spring, 
MD). For short term growth, cells were cultured in RPMI-1640 (Irvine Scientific, Santa 
Ana, CA) supplemented with I0% heat-inactivated fetal calf serum (KC Biologicals, 
Lexena, KS), 1 mM glutamine (Gibco, Grand Island, NY), antibiotics, and 10% purified 
IL-2. 
Morphology. Giemsa-stained specimens were prepared as described (29). 
Results 
Coexpression ofCD3 and IgG-FcR (CD16/Leu-11 Antigen) on PBL. In a routine 
phenotypic analysis of the PBL obtained from normal, healthy donors at our 
institute, we observed two individuals (D. H. and L. G.) who possessed a
significant proportion of iymphocytes coexpressing CD3 and CD16 (Leu-11) 
antigens. As shown in Fig. 1, 23.6% of D. H.'s lymphocytes and 9.4% of L. G.'s 
lymphocytes were CD3+,CD16÷; whereas 46.6% (D. H.) and 61.0% (L. G.) of 
lymphocytes were typical T iymphocytes with the phenotype CD3+,CD16-. The 
proportion of CD3-,CD16 + NK cells was within the normal range for both 
individuals (18.0%, D. H.; 14.0%, L. G.). Peripheral blood from both L. G. and 
D. H. have been sequentially monitored over the past 6 and 18 mo, respectively, 
with no significant change in the proportion of CD3+,CD16 +lymphocytes or 
absolute lymphocyte number. 
The specificity of antibody binding was established by the findings that: (a) 
An equal percentage of CD3 ÷ cells were costained with both IgM (anti-Leu-1 lb) 
and IgGl (anti-Leu-1 la) mAb against acommon epitope on the IgG-FcR. Neither 
control IgM nor IgG1 mAb reacted with a subset o f t  lymphocytes (Fig. 1). (b) 
Coexpression of CD 16 and CD3 antigens was also demonstrated using the anti- 
Leu- 11 c/B73.1 (Fig. 4) and OKT3 antibodies (not shown). Anti-Leu- 11 c/B73.1 
reacts with a different epitope on the Fc-IgG receptor that does not inhibit the 
binding of the anti-Leu-1 l a and -b antibodies (12). (c) Two-color immunofluo- 
rescence using F(ab')2 fragments of anti-Leu-4 and anti-Leu-1 la confirmed that 
a subset of CD3 ÷ T lymphocytes coexpressed the CD16 antigen (Fig. 2). 
FcR-bearing CD3 + T cells could be distinguished by the levels of FcR and 
CD3 surface antigen expression compared to other cell types. The apparent 
density of CD16 antigen on the CD3 + T lymphocytes was significantly less than 
on the CD3- subset. Moreover, the apparent amount of CD3 antigen was 
significantly higher on the CD3+,CD16 ÷compared with the CD3+,CD16 - cells 
(Figs. 1 and 2). In an independent experiment, he amount of fluorescence was 
quantitated by determining the mean fluorescence value for each population 
(Fig. 3). The upper panels display the fluorescence histograms for FITC-anti- 
Leu-11 a and phycoerythrin (PE) anti-Leu-4 binding to L. G.'s lymphocytes. Note 
that the anti-Leu-11-stained cells show three distinct populations: an unstained 
population, ceils with low density (dim) CD16 antigen (11.6% of lymphocytes), 
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FIGURE 1. Coexpression of CD3 and CD16 on normal PBL. Peripheral blood mononuclear 
cells from two individuals (D. H. ]upper panels] and L. G. ]lower panels]) were stained with 
fluorochrome-conjugated control antibodies (lej~); FITC-anti-Leu-1 la (IgG1 antibody) and 
PE-anti-Leu-4 (middle); and FITC-anti-Leu-1 lb (IgM antibody) and PE-anti-Leu-4 (right). 
Lymphocytes were distinguished from monocytes on the basis of their characteristic 90 ° and 
forward angle light scatter profiles. Correlated green (abscissa, four-decade log scale) and red 
(ordinate, four-decade log scale) fluorescence of the lymphocytes are displayed as contour 
plots. Based on the Ig control sample, the contour plots were divided into quadrants: I, cells 
with red fluorescence only; II, cells with red and green fluorescence; III, unstained cells; and 
IV, cells with green fluorescence only. The number of cells within each quadrant was 
determined and the percentage of the total number of lymphocytes calculated. Analysis of D. 
H.'s lymphocytes indicated: 46.6% CD3÷,CD16-; 23.6% CD3+,CD16÷; and 18.1% CD3- 
,CD16 +. For L. G.'s lymphocytes, 61.0% CD3+,CD16-; 9.4% CD3+,CD16+; and 14.0% 
CD3-,CD16 +. In the control contour plots, >98% of lymphocytes were in quadrant III 
(unstained). 
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FIGURE 2. Two-color immunofluorescence using F(ab')~ fragments of anti-Leu-11 and anti- 
Leu-4. Nonadherent PBL from D. H. were stained with FITC-conjugated F(ab')~ anti-Leu-4 
and biotin-conjugated F(ab')= anti-Leu-1 la mAb (B) or appropriate control IgG antibodies 
(A). PE-conjugated streptavidin was used to detect binding of biotin-conjugated antibodies. 
Data are presented as described in Fig. 1. 
and cells with high density (bright) CD 16 antigen (13.2%). As shown previously 
(8, 12, 31), this dim CD 16 + subset is absent from most normal individuals. Gates 
were set on these three distinct subsets, and the PE-anti-Leu-4 staining was 
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FIGURE 3. Quantitation of CD3 and CD16 antigen expression. Peripheral blood mononu- 
clear cells (L. G.) were stained with: FITC-lgG1 and PE-IgG1 control antibodies, or F ITC-  
anti-Leu- 11 a and PE-anti-Leu-4 antibodies. Data were collected in list-mode files and displayed 
as histograms (abscissa, 256 channels, four-decade log scale; ordinate, relative number of cells). 
In A and B, the fluorescence from the stained sample (solid line) is superimposed over the 
fluorescence of the control sample (broken line). The percentage of stained cells and relative 
amount of fluorescence (indicated in the parenthesis as arbitary linear fluorescence units) are 
shown. Note that in A there are three distinct populations of cells in the anti-Leu-1 la-stained 
sample: unstained, dim CD16 ÷ (11.6%), and bright CD16 ÷ (13.2%) cells. In C, E, and G, a 
gate was placed on each of these subpopulations and the anti-Leu-4 staining profile was 
displayed for the selected population. The ordinate was rescaled in each panel to permit 
optimal visualization of the results. 
displayed for each population. Within the dim CD16 + cells, 82.9% expressed the 
CD3 antigen. In contrast, only 2% of the bright CD16 + cells expressed CD3. 
Quantitative comparison of the populations indicated that the dim CD16 + cells 
expressed ~10% of the CD16 antigen compared to the bright CD16 + cells. The 
dim CDI6 ÷ cells were also unique in that they showed about twice as much CD3 
antigen as the typical CD3+,CD16- T lymphocytes (Fig. 3). Quantitative studies 
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with D. H.'s lymphocytes were essentially identical to those presented for L. G.'s 
lymphocytes (not shown). 
PBL obtained from L. G. and D. H. were analyzed by two-color immunofluo- 
rescence using PE-conjugated anti-Leu-1 lc/B73.1 and a panel of FITC-conju- 
gated antibodies against other T cell- and NK cell-associated ifferentiation 
antigens. The results using L. G.'s lymphocytes are presented in Fig. 4. As shown 
in Figs. 1-3, two distinct populations of CD16 + (Leu-1 lc +) lymphocytes could 
be identified based on the amount of CD16 antigen present on the cell surface. 
The majority of dim CD 16 + cells coexpressed the pan-T cell-associated antigens 
CD3 (Leu-4) and CD5 (Leu-1). In contrast, the bright CD 16 + cells lacked these 
pan-T cell antigens. However, as shown in the lower left panel, CD8 (Leu-2) 
antigen was apparently expressed in low amounts on a small proportion of both 
the dim and bright CD16 + lymphocytes. Expression of low amounts of CD8 
antigen on a minor proportion of CD 16 + lymphocytes has been reported previ- 
ously (8). CD4 (Leu-3) was not coexpressed on CD16 + lymphocytes (Fig. 4), 
indicating that most CD16 + lymphocytes (both dim and bright subsets) lack 
expression of either the CD4 or CD8 antigen. Furthermore, HLA-DR, CD19 
(Leu-12), IL-2-R, and Leu-M3 also were not coexpressed on CD16 + lymphocytes 
(not shown). A subset of CD16 + cells coexpressed the Leu-7 antigen (Fig. 4), and 
a majority of CD16 + lymphocytes (both dim and bright CD16 +) were found to 
coexpress the CR3 (Leu-15) and CD2 (Leu-5) antigens (not shown). Qualitatively, 
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FIGURE 4. Coexpression of T cell-associated antigens on CD16 + lymphocytes. Peripheral 
blood mononuclear cells (L. G.) were stained with: FITC-IgG and PE-IgG control antibodies; 
F1TC-anti-Leu-4 and PE-anti-Leu-11 c/B73.1 ;FITC-anti-Leu-1 and PE-anti-Leu-11 c/B73.1 ;
FITC-anti-Leu-2a and PE-anti-Leu-llc/B73.1; FITC-anti-Leu-3a and PE-anti-Leu- 
1 lc/B73.1; and FITC-anti-Leu-7 and PE-anti-Leu-1 lc/B73.1. Data are presented as de- 
scribed in Fig, 1. Quantitation of the data revealed: 10,6% CD3 + (Leu-4+), CD16+; 11.1% 
CD5 ÷ (Leu-I +), CD16+; 6.3% CD8 + (Leu-2+), CD16+; <1% CD4 + (Leu-3+), CDI6+; and 13.3% 
Leu-7+,CDI6 + lympbocytes. >98% of lymphocytes were in quadrant III (unstained) in the 
control sample. 
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essentially identical profiles were observed when D. H.'s lymphocytes were 
examined using this panel of reagents (not shown). 
PBL from 46 normal, random blood donors were examined for coexpression 
of the CD3 and CD 16 surface antigens. Most individuals examined (40/46) had 
low (<2%) to undetectable l vels of circulating CD3+,CD 16 + cells. Six individuals 
expressed >2% CD3+,CD16 +lympbocytes. In three of these six individuals, the 
CD3+,CD16 +cells comprised 2-5% of lymphocytes. Only lymphocytes from 
three individuals, including D. H. and L. G., contained >5% CD3+,CD16 +cells. 
In all cases observed, the amount of CD16 antigen expressed on the CD3 + T cell 
subset was significantly less than on the CD3- NK cell population. 
L. G.'s parents were analyzed and found to have <1% CD3+,CD16 +lympho- 
cytes. The families of two other individuals (caucasians of european ancestry) 
who demonstrated significantly higher proportions of these cells were also 
examined (Table I). Most family members had <1% CD3+,CD16 +lymphocytes 
(pedigree charts given in Fig. 5). 
Cytolytic Activity of CD3+,CD16 + and CD3-,CD16 + Lymphocytes. Lymphocytes 
from D. H. were stained with FITC-anti-Leu-1 la and PE-anti-Leu-4 (CD3). 
The CD3-,CD 16 + and CD3÷,CD 16 + cells were isolated by two-color cell sorting. 
Reanalysis of the purified subpopulations indicated >95% purity. As shown in 
Fig. 6, CD3+,CD16 +cells were mononuclear lymphocytes with distinct azuro- 
philic granules. The cells were tested for cytotoxic activity against the NK- 
sensitive tumor cell line K562 immediately after isolation and after 1 wk of 
culture in IL-2 (Fig. 7). The CD3-,CD16 + NK cells mediated cytolysis of K562, 
which was augmented by IL-2 treatment. Additionally, IL-2 activation enabled 
TABLE I 
Coexpression ofCD3 and CD16: Normal Donors and Family Studies 
Individuals tested 
Phenotype (percent of lymphocytes) 
CD3-,CD16 ÷ CD3÷,CD16 + CD3÷,CD16 - 
Family 1 
1 8 7 77 
2 7 <1 84 
3 5 <1 86 
4 3 3 86 
5 5 <1 86 
Family 2 
1 7 3 77 
2 6 1 81 
3 2 4 82 
4 4 3 86 
5 4 1 83 
6 5 <l  83 
7 3 1 82 
8 7 1 81 
Peripheral blood mononuclear cells were stained with FITC anti-Leu-1 la 
and Texas Red-avidin/biotin anti-Leu-4, or appropriate fluorochrome- 
conjugated Ig controls. Based on the control sample, the percentage of
lymphocytes with the indicated antigenic phenotype was determined. 
FIGURE 5. Pedigree charts of 
families tudied in Table I. 
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FIGURE 6. Morphology. CD3+,CD 16- T cells (A); CD3+,CD 16 ÷ T cells (B); and CD3-,CD 16 ÷ 
NK cells (C), isolated as escribed in Fig. 7, were cytocentrifuged onto glass lides and stained 
with Giemsa. Magnification, × 5,500. 
the CD3-,CD16 + cells to lyse the relatively NK-insensitive CCRF-SB cell line 
(Fig. 7). The  CD3+,CD16 + cells showed little cytolytic activity, either before or 
after IL-2 treatment (Fig. 7). Comparison of the cytotoxicity of unstained cells 
and cells stained with anti-Leu-4 or anti-Leu-11 indicated that these antibodies 
did not inhibit activity. K562 lysis was slightly increased in the anti-Leu-4-stained 
cells compared to unstained cells (not shown). 
We were unable to directly access the ADCC activity of the freshly isolated 
CD3+,CD16 + and CD3-,CD16 + cells, since the anti-Leu-11 antibody efficiently 
inhibits ADCC function (12, 13). However, to determine whether ADCC activity 
was present in D. H.'s T cell population, nonadherent peripheral blood mono- 
nuclear cells were stained with FITC-anti-Leu-1 (CD5) antibody, and the cells 
were separated into CD5- and CD5 + subpopulations using a fluorescence-acti- 
vated cell sorter (FACS). As shown in Fig. 8, significant ADCC activity was 
detected in both the CD5 + and CD5- populations. Furthermore,  addition of 
anti-Leu-11 antibody to the assay completely inhibited the ADCC mediated by 
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FIGURE 7. NK cell activity of CD3+,CDI6 ÷and CD3-,CD16 + lymphocytes. Nonadherent 
PBL (D. H.), depleted of B cells using a nylon wool column, were stained with FITC-anti- 
Leu-1 la and PE-anti-Leu-4. The CD3 + ,CDI6 ÷ and CD3-,CD16 + cells were separated using 
the FACS. Reanalysis of the separated subpopulations i dicated >95% purity. Morphological 
examination revealed that >99% of the sorted cells were lymphocytes. The sorted subpopu- 
lations and stained, unsorted lymphocytes were tested for cytotoxic activity against 5tCr- 
labelled K562 tumor cells in a 4-h radioisotope-release assay (A). The CD3+,CDI6 +and 
CD3-,CD16 + cells were placed in culture medium containing purified IL-2, and again tested 
for cytotoxic activity against K562 and CCRF-SB tumor cells after 1 wk (B). Analysis of the 
antigenic phenotypes after 1 wk in culture indicated that the CD3-,CD164 and CD3+,CDI64 
populations contained -98% CD3-,CD164 and CD3+,CD164 cells, respectively. 2% of the 
cells in the CD3+,CD164 culture were CD3-,CD16 + cells. By extrapolation f the effector/ 
target (E/T) curves, this small contamination f activated CD3-,CD 164 NK cells may account 
for the low levels of cytotoxicity observed against K562 in the CD3+,CD 164 population. 
both the CD5-  and CD5 + subsets. In contrast, antibody against CR3 (Leu-15), 
an antigen present on both the CD3÷,CD16 - and CD3+,CD16 ÷cells, failed to 
affect ADCC activity. By direct two-color immunofluorescence analysis, ~21.4% 
of the CD5 ÷ T lymphocytes coexpressed CD16, whereas 63.4% of the CD5- 
lymphocytes were CD16 ÷ NK cells. These data suggest hat a CD16-associated 
FcR was involved in the ADCC mediated by both populations. 
Proliferation of CD3+,CD16 + Lymphocytes Cocultured with Allogeneic Tumor Cell 
Lines. The CD3+,CD 16 ÷ and CD3-,CD 16 + cells were cocultured with irradiated 
NK-sensitive K562 tumor cells, irradiated NK-insensitive CCRF-SB B lympho- 
blastoid cells, or purified IL-2 for 6 d. As shown in Table II, CD3-,CD16 + cells 
proliferated vigorously in response to K562 and IL-2, but less well in response 
to CCRF-SB. Consistent with our previous findings (32), the response of  the 
CD3- ,CD16 + NK cells was only partially inhibited (~20%) by the presence of 
anti-IL-2-R (TAC) antibody in the culture. In contrast, the CD3÷,CD16 ÷popu- 
lation was strongly stimulated by both K562 and CCRF-SB. Furthermore, anti- 
IL-2R antibodies inhibited the response against CCRF-SB by 75%, compared to 
only 25% against K562. The proliferative response by the CD3+,CD16 ÷ cells 
cultured in IL-2 similarly was greatly inhibited (89%) by the presence of anti-IL- 
2-R antibody. 
Culture ofCD3+,CD16 +Lymphocytes. CD3+,CD16 ÷and CD3-,CD16 + lympho- 
cytes were placed into culture and maintained as IL-2-dependent cell lines. The 
CD3+,CD16 + cells had a 24-48-h generation time, whereas the CD3-,CD16 + 
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FIGtm~ 8. ADCC activity of CD5- and CD5 ÷ lymphocytes and inhibition by anti-Leu-11 
antibody. Nonadherent peripheral blood mononuclear cells from D. H. were stained with 
FITC-anti-Leu-1 (CD5) and separated into CD5 ÷ and CD5- subsets using a FACS. Reanalysis 
indicated 98% purity. A: CD5- and CD5 ÷ lymphocytes were tested for ADCC activity against 
5~Cr-labelledJY tumor cells preincuhated with an IgG2a anti-HLA mAb, ME1. No cytotoxicity 
was observed against JY cells not preincubated with antibody. B: Anti-Leu-11 or anti-Leu-15 
mAb were added to the ADCC assay at 5 ug/ml. JY target cells do not express the CD 16 (Leu- 
11) or CRs (Leu-15) antigens. 
cells grew more slowly. The  growth of these cells was dependent on the presence 
of IL-2. After 3 wk in culture, these cells were assayed for ADCC activity and 
NK cel l-mediated cytotoxicity against the JY lymphoblastoid B cell line. IL-2 
cultured CD3-,CD16 + NK cells demonstrated high levels of cytotoxicity against 
JY in the absence of  antibody (Fig. 9). This is consistent with prior observations 
(32) that CD16 + NK cells can lyse both NK-sensitive and NK-insensitive targets 
after activation with IL-2. The  high background of  NK activity against JY in the 
absence of  antibody (78% specific iysis at an effector/target ratio of  4:1) obscured 
any ADCC activity. In contrast, CD3+,CD16 + cells mediated only low levels of  
JY cytotoxicity in the absence of  antibody. Using an IgG2a switch-variant of  the 
anti-HLA mAb MA2.1, we observed significant ADCC activity. The  parent IgG 1 
MA2.1 antibody, however, failed to cause any increase inJY cytolysis. The  IgG2b 
switch-variant of  MA2.1 directed only a modest increase in cytotoxicity. 
Phenotypic analysis of the CD3+,CD16 + ceils after 3 wk in culture indicated 
that ~95% retained the CD3 and CD16 antigens. The  amount of  CD16 and 
CD3 antigen on these cells after short-term culture in IL-2 was approximately 
the same as present on the freshly isolated lymphocytes. Furthermore,  the cells 
expressed IL-2-R (40%), HLA-DR antigens (95%), CD2 (83%), and CD5 (95%). 
As with the freshly isolated cells (Fig. 3), the majority of  the cultured cells (~80%) 
expressed neither the CD4 nor CD8 antigens. That  CD3+,CD16 + cells expressed 
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TABLE II 
Alloantigen and IL-2 Stimulation of CD3+,CD16 + Lymphocytes 
2099 
Responder 
[3H]Thymidine Percent 
inhibition Stimulator Antibody incorporation SI with anti- 
(cpm +_ SD) body 
Control PBL 
D. H. PBL 
CD3-,CD16 + (D. H.) 
CD3+,CD16 ÷(D. H.) 
None None 6,790 --- 230 - -  - -  
IL-2 Control 81,640 4- 310 14.1 - -  
IL-2 Anti-IL-2-R 35,898 4- 620 6.2 56 
K562 Control 136,644 4- 740 23.6 - -  
K563 Anti-IL-2-R 105,378 4- 1,120 18.2 22 
CCRF-SB Control 160,962 - 1,260 27.8 - -  
CCRF-SB Anti-IL-2-R 55,005 - 891 9.5 65 
None None 7,600 -4- 820 - -  - -  
IL-2 Control 89,680 4- 360 11.5 - -  
IL-2 Anti-IL-2-R 45,600 + 420 6.0 48 
K562 Control 123,880 +- 1,160 16.3 - -  
K562 Anti-IL-2-R 75,520 -+ 1,000 10.2 37 
CCRF-SB Control 209,000 -+ 1,421 27.5 - -  
CCRF-SB Anti-IL-2-R 99,560 + 680 13.1 52 
None None 230 _ 160 - -  - -  
IL-2 Control 8,809 4- 165 38.3 - -  
IL-2 Anti-IL-2-R 6,785 _+ 220 29.5 22 
K562 Control 21,919 4- 631 95.3 - -  
K562 Anti-IL-2-R 17,296 4- 412 75.2 21 
CCRF-SB Control 1,886 4- 206 8.2 - -  
CCRF°SB Anti-IL-2-R 1,081 --- 151 4.7 42 
None None 294 + 110 - -  - -  
IL-2 Control 7,908 + 375 26.9 - -  
IL-2 Anti-IL-2-R 823 + 120 2.8 89 
K562 Control 28,224 4- 410 96.0 - -  
K562 Anti-IL-2-R 21,109 4- 593 71.8 25 
CCRF-SB Control 11,789 -+ 295 40.1 - -  
CCRF-SB Anti-IL-2-R 2,881 + 173 9.8 75 
CD3+,CD16 +and CD3-,CD16 ÷ lymphocytes from D. H. were isolated as described in Fig. 7. 
CD3+,CD16+; CD3-,CD16+; and unseparated PBL from D. H. and a random, normal donor were 
cocultured with purified IL-2 (10% vol/vol) or with mitomycin C-treated K562 or CCRF-SB cells at 
a responder/stimulator ratio of 1 : 1. Anti-IL°2-R or an isotype-matched control Ig were added to the 
indicated cultures at a final concentration of 100 #g/ml. After 5 d, wells were pulsed with [SH]- 
thymidine and harvested. The mean cpm _ SD of triplicate wells are presented. The stimulation 
index (SI) was calculated as: (mean cpm stimulated cultures)/(mean cpm unstimulated culture). 
funct iona l  FcR  was conf i rmed by the i r  abi l i ty  to speci f ica l ly  b ind  d imer ic  rabb i t  
IgG.  Th is  b ind ing  was complete ly  inh ib i ted  by ant i - Leu-1  1 mAb.  
Anti-CD3 Directs Non-antigen-specific Cytotoxicity by CD3+,CD16 + Cells. 
Recent ly  (33,  34) it has  been  repor ted  that  ant igen-spec i f i c ,  ma jor  h i s tocompat -  
ibi l i ty complex  (MHC) - res t r i c ted  cyto tox ic  CD3 + T cell c lones  may kill i nappro -  
p r ia te  ta rget  cel ls in the  presence  o f  ant i -CD3 ant ibod ies .  As  shown in Fig. 10, 
cu l tu red  CD3+,CD16 + cel ls  kill the  re la t ive ly  NK- insens i t i ve  JY  and  LCL  207 B 
lymphob las to id  cell  l ines in the  presence  o f  ant i - Leu-4  (CD3).  Because  the  ta rgets  
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FmURE 9. ADCC activity of CD3+,CD16 ÷lymphocytes. After 3 wk culture in IL-2-contain- 
ing medium, CD3-,CD16÷and CD3÷,CD16 ÷lymphocytes were tested for NK cell-mediated 
cytotoxicity against he JY B lymphoblastoid cell line in a 4-h radioisotope-release say (A). 
In B, the ADCC activity of the CD3+,CD 16 ÷ cells was tested in a 4-h radioisotope-release say 
using 5~Cr-labelled JY cells preincubated with isotype switch-variants of the MA2.1 (anti-HLA- 
A2-specific) mAb. 
do not express CD3, this cytotoxicity was induced by the interaction of anti-CD3 
with the effector cells. As demonstrated lsewhere 2 (35), the cytolytic activity of 
CD3-,CD16 + NK cells was unaffected by anti-CD3 mAb. 
The role of class I MHC molecules in the anti-CD3-induced cytotoxicity was 
examined using Daudi as a target cell line. Although Daudi does not express 
class I MHC molecules, these B lymphoblastoid cells were lysed efficiently by 
CD3+,CD16 +cells, but only in the presence of anti-Leu-4 (CD3) antibody (Fig. 
10). Unlike anti-Leu-4, the addition of anti-Leu-11 antibody to the cultures failed 
to induce cytotoxicity against Daudi (Fig. 10). 
Discussion 
In most individuals, cells with the phenotype CD3+,CD16 +comprise <2% of 
total PBL (8-10, 12, 30, 31). However, we have recently identified several 
healthy individuals who possess ignificant levels of these cells in their peripheral 
blood. In this study, we have examined the antigenic, morphological, and 
functional properties of this unique subset of T iymphocytes. 
FcR for IgG are expressed on two distinct populations of human lymphocytes. 
The majority of these FcR + lymphocytes lack the CD3 antigen, and mediated 
NK cell-mediated cytotoxicity (5-7). Expression of IgG FcR on a very minor 
subpopulation of CD3 + T lymphocytes has been previously identified (5-7, 23) 
using either EA rosette procedures or dimeric rabbit IgG complexes. However, 
due to the low levels of these cells in most individuals, and the technical difficulties 
involved in efficiently separating the CD3+,FcR + and CD3-,FcR + subsets, there 
2 Phillips, J. H., and L. L. Lanier. 1985. Lectin-dependent and anti-CD3-induced cytotoxicity are 
mediated by peripheral blood cytotoxic T lymphocytes expressing the Leu-7 antigen. Manuscript 
submitted for publication. 
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FIGURE 10. Anti-CD3-induced cytotoxicity mediated by CD3+,CD16 ÷lymphocytes. After 3 
wk in culture in I L-2-eontaining medium, CD3÷,CD 16 ÷ lymphocytes were tested for cytotoxic 
activity against the JY, Daudi, and LCL 207 B cell lines in the presence or absence of anti- 
Leu-4 mAb (4 ~g/ml) or anti-Leu-11 mAb (4 gg/ml; Daudi experiment). 
have been few functional studies comparing these populations. Furthermore, it
has been unclear whether or not FcR present on CD3 + T lymphocytes would be 
recognized by anti-Leu-11 and similar antibodies that react with the FcR present 
on CD3- NK cells and granulocytes. In our experiments, we have shown that, in 
certain individuals, a subset of T cells can express the FcR recognized by the 
anti-Leu-11 antibody, and that these CD3+,CD16 +T cells can mediate ADCC 
via this FcR. Consistent with these cells being within the T cell lineage, we have 
shown that essentially all of  the CD3+,CD16 ÷ lymphocytes coexpress CD2 
(E rosette receptor) and CD5 (Leu-1) antigens. Furthermore, anti-Leu-4 anti- 
body immunoprecipitates a 22-29 kD protein complex from the cell surface of 
these CD3÷,CD16 + lymphocytes, similar to the CD3 antigen isolated from 
CD3+,CD16 - T lymphocytes (our unpublished observation). It is unresolved 
whether the CD3÷,CD16 +cells represent a monoclonal or polyclonal population 
of T lymphocytes. Since it is possible to culture these cells in IL-2, we may be 
able to examine this question in future studies. 
These CD3+,CD16 +tymphocytes are different han typical T ceils in several 
aspects. Unlike resting T lymphocytes, CD3÷,CD 16 + have numerous azurophilic 
granules, similar to NK cells and in vitro-activated cytotoxic T lymphocytes. 
Furthermore, unlike most T lymphocytes CD3+,CD16 ÷ lymphocytes lack detect- 
able surface xpression of either CD4 or CD8. Since these antigens are implicated 
(36-38) in cell-cell interactions involving class II and class I antigens, respectively, 
failure to express CD4 and CD8 suggests that CD3+,CD 16 ÷ cell may not require 
MHC gene products for target cell recognition. CD3+,CD16 ÷ cells were also 
distinct in that they expressed approximately twice the level of CD3 as CD16- T 
lymphocytes, and expressed lower levels of CD5 than most other T cells. 
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Furthermore, this subset expressed approximately one-tenth the level of CD16 
found on the CD3-,CD16 + NK cells. This is corroborated by the low level of 
binding observed when these cells were stained with FITC-labeled dimeric rabbit 
IgG. Due to the low levels of FcR expression, the frequency of this cell population 
may have been underestimated in many studies. Unless immunofluorescent 
reagents and immunofluorescence detection systems are optimized, this popula- 
tion may be undetectable. 
This CD3+,CD 16 + population lacked NK activity. However, these cells could 
be rendered cytotoxic by two mechanisms. The CD3+,CD16 +cells efficiently 
mediated ADCC activity against antibody-coated targets. These cells may mediate 
a similar function in vivo, thereby providing a cytotoxic T lymphocyte with the 
capacity to recognize and lyse an antibody-coated target through a structure 
distinct from the T cell antigen receptor. Although there have been reports (15, 
16) that T cells isolated from patients with certain lymphoproliferative disorders 
can mediate ADCC, but not NK activity, the isolation of this T cell subset from 
the peripheral blood of a normal, healthy individual has not been reported. As 
previously demonstrated for CD3-,CD16 + NK cells (13), the CD3+,CD16 +T 
cells preferentially mediate ADCC with IgG2a antibodies. IgG2b antibodies were 
less efficient, whereas IgG1 antibodies demonstrated no significant cytotoxicity. 
These data suggest hat the FcR on these CD3 + T cells is functionally and 
antigenically quite similar to the FcR present on CD3- NK cells. However, 
further comparative studies on the biochemical structure of these receptors will 
be required to address this issue. 
CD3+,CD16 +lymphocytes were also rendered cytotoxic against several NK- 
resistant B lymphoblastoid cell lines when anti-Leu-4 (CD3) antibody was present 
in the assay. Recently, several investigators (33, 34) have demonstrated that 
antigen specific cytotoxic T cells can nonspecifically se tumor cell targets in the 
presence of anti-CD3 mAb. Since the CD3 antigen is structurally associated with 
the T cell antigen receptor heterodimer (39-43), anti-CD3 antibodies may induce 
cytotoxic activity in cytotoxic T lymphocytes by antigenic mimicry. Although the 
antigenic specificity of the CD3+,CD16 +population is unknown, we show here 
that anti-CD3 can induce significant cytotoxic activity. The anti-CD3-induced 
cytotoxicity does not require recognition of class I MHC antigens on the target, 
since the CD3+,CD 16 + cells lysed Daudi efficiently. 
Since CD3+,CD16 +can mediate both ADCC and nonspecific ytotoxicity in 
the presence of anti-CD3 antibodies, it is possible that the two mechanisms may 
be related. Binding to the FcR may perturb the CD3-T cell antigen receptor 
complex, thus stimulating cytotoxic activity. Contrary to this hypothesis, how- 
ever, is our observation that soluble anti-Leu-11 antibody did not induce cyto- 
toxicity in the CD3+,CD16 +population. Whether anti-Leu-11 complexed to an 
insoluble matrix may activate these cells remains to be determined. 
The proliferative response of the CD3+,CD16 + population shares certain 
features with both typical T lymphocytes and NK cells. We have shown that NK 
cells (CD3-,CD16 +) proliferate vigorously when cocultured with NK-sensitive 
K562 tumor cells, and that they proliferate poorly when cultured with a B 
lymphoblastoid cell line, CCRF-SB (30). In contrast, T lymphocytes 
(CD3+,CD 16-) are stimulated preferentially by CCRF-SB. Furthermore, the two 
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cell types were functionally distinguished in that the T cell response, but not the 
NK cell response, could be significantly inhibited by anti-IL-2-R antibody (30). 
In this study, the CD3+,CD16 + population was stimulated by coculture with 
either K562 or CCRF-SB. The response against CCRF-SB was much more 
sensitive to inhibition by anti-IL-2-R antibody than the response against K562. 
It is unlikely that the strong response against K562 was due to contamination by 
NK cells, since reanalysis of the isolated population showed <1% CD3-,CD16 + 
cells. It is possible that the CD3+,CD 16 + population is heterogeneous, with some 
cells responding to K562 and others to CCRF-SB. Alternatively, each cell may 
possess two distinct mechanisms for activation, one of which is resistant o 
inhibition by anti-IL-2-R antibody. 
The origin and relationship of CD3+,CD16 +T cells to FcR- T cells are not 
known. In previous studies we did not observe induction of CD16 antigen 
expression on T lymphocytes upon activation with mitogens or alioantigens. 
Furthermore, after 3 wk of culture in IL-2, CD3+,CD16 +cells retained expres- 
sion of both the CD3 and CD16 antigens. Stable surface expression of CD16 on 
these CD3+,CD16 +cytotoxic T cells in both D. H. and L. G.'s peripheral blood 
was found over an observation period of 18 and 6 mo, respectively. This indicates 
that these cells are not present as a consequence of acute infection. Furthermore, 
both L. G. (female) and D. H. (male) are healthy individuals (25-35 y old) with 
no known illness. It may be noteworthy that these individuals are both oriental, 
since Prince et al. (44) reported the level of CD 16 ÷ lymphocytes tobe significantly 
elevated in certain Chinese individuals. However, a limited study of other 
Chinese individuals did not reveal many to have high levels of circulating 
CD3+,CD16 +lymphocytes (L. Lanier and H. Prince, unpublished observation). 
Family studies described here demonstrate r latively high proportions of circu- 
lating CD3+,CD16 +cells in persons of other ethnic backgrounds. The distribu- 
tion of CD3+,CD16 +cells within these families suggests genetic mechanisms may 
operate to influence the proportion of these cells in peripheral blood. Further 
studies are required to test this hypothesis. 
Summary 
A subset of peripheral blood T lymphocytes coexpressing CD3 and IgG Fc 
receptors (FcR) (CD16/Leu-l l  antigen) have been identified, isolated, and 
functionally characterized. The CD3÷,CD16 + cells were established in short- 
term culture using growth medium containing interleukin 2 (IL-2). Both the 
freshly isolated cells and the cultured cell line stably expressed the CD3÷,CD16 +
phenotype. Furthermore, a majority of these T cells lacked either CD4 or CD8 
expression. Like in vitro-activated cytotoxic T iymphocytes and natural killer 
(NK) cells, the CD3+,CD16 +cells showed numerous azurophilic granules. Al- 
though these ceils failed to mediate significant levels of NK cell-mediated 
cytotoxicity even after stimulation with IL-2, they efficiently functioned as 
effectors of antibody-dependent cellular cytotoxicity (ADCC). The Ig isotype 
specificity of the ADCC was analyzed using an isotype switch-variant family of a 
murine anti-HLA monoclonal antibody (mAb). Similar to the CD3-,CD16 + NK 
cell population, the CD3+,CD16 +T cells preferentially used the IgG2a antibody 
to mediate ADCC. The CD3÷,CD 16 + cells demonstrated a proliferative response 
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when cocultured with either a NK-sensitive tumor cell line, K562, or a NK- 
insensitive B lymphoblastoid cell line, CCRF-SB. The response against CCRF-SB 
was significantly inhibited by anti-IL-2 receptor antibody, whereas the response 
against K562 was only partially diminished. Cytotoxicity was also induced in the 
CD3+,CD16 + population by the presence of anti-CD3 mAb, indicating that 
cytotoxicity can be triggered by stimulation via the CD3-T  cell antigen receptor 
complex. By isolating these CD3+,CD16 ÷ cells from the peripheral blood of a 
normal, healthy individual, it has been possible to extensively study the mor- 
phology, antigenic phenotype, and functional behavior of this unique subset of 
T lymphocytes expressing IgG FcR. 
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